China Resources Double-Crane Pharmaceutical Co Ltd Tangible Net Worth Ratio
China Resources Double-Crane Pharmaceutical Co Ltd tangible net worth ratio. China Resources Double-Crane Pharmaceutical Co Ltd (600062) has a Tangible Net Worth Ratio of 80.0% as of September 2025. This metric is calculated by deducting intangible assets (CN¥2.43 Billion) from net assets (CN¥12.16 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore China Resources Double-Crane Pharmaceuti annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of China Resources Double-Crane Pharmaceutical Co Ltd (1994–2024)
Tangible net worth ratio of China Resources Double-Crane Pharmaceutical Co Ltd from 1994 to 2024. This chart shows how China Resources Double-Crane Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 31 annual periods from 1994 to 2024. As of September 2025, the ratio stands at 80.0%, reflecting net assets of CN¥12.16 Billion with intangible assets of CN¥2.43 Billion CNY. Check China Resources Double-Crane Pharmaceuti strategic capital allocation to assess the company's strategic physical and investment asset allocation.
China Resources Double-Crane Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (1994–2024)
China Resources Double-Crane Pharmaceutical Co Ltd tangible net worth ratio by year from 1994 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for China Resources Double-Crane Pharmaceutical Co Ltd from 1994 to 2024, covering 31 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of China Resources Double-Crane Pharmaceuti.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 77.7% | CN¥11.11 Billion | CN¥2.47 Billion | CN¥16.69 Billion | ▼ -0.6 pp |
| 2023 | 78.3% | CN¥11.79 Billion | CN¥2.56 Billion | CN¥15.43 Billion | ▼ -0.4 pp |
| 2022 | 78.7% | CN¥10.73 Billion | CN¥2.28 Billion | CN¥14.48 Billion | ▼ -3.1 pp |
| 2021 | 81.9% | CN¥10.48 Billion | CN¥1.90 Billion | CN¥13.68 Billion | ▼ -0.5 pp |
| 2020 | 82.4% | CN¥9.38 Billion | CN¥1.65 Billion | CN¥12.42 Billion | ▲ +1.3 pp |
| 2019 | 81.1% | CN¥8.68 Billion | CN¥1.64 Billion | CN¥11.28 Billion | ▲ +0.4 pp |
| 2018 | 80.7% | CN¥7.91 Billion | CN¥1.53 Billion | CN¥10.31 Billion | ▼ -2.5 pp |
| 2017 | 83.2% | CN¥7.85 Billion | CN¥1.32 Billion | CN¥9.44 Billion | ▼ -2.1 pp |
| 2016 | 85.3% | CN¥7.04 Billion | CN¥1.03 Billion | CN¥8.24 Billion | ▲ +0.5 pp |
| 2015 | 84.8% | CN¥6.43 Billion | CN¥977.97 Million | CN¥7.76 Billion | ▼ -8.4 pp |
| 2014 | 93.2% | CN¥5.68 Billion | CN¥385.42 Million | CN¥6.62 Billion | ▲ +0.4 pp |
| 2013 | 92.8% | CN¥5.34 Billion | CN¥384.73 Million | CN¥6.48 Billion | ▲ +0.1 pp |
| 2012 | 92.7% | CN¥4.71 Billion | CN¥342.96 Million | CN¥6.51 Billion | ▼ -0.2 pp |
| 2011 | 92.9% | CN¥4.34 Billion | CN¥307.89 Million | CN¥6.08 Billion | ▼ -1.2 pp |
| 2010 | 94.1% | CN¥3.93 Billion | CN¥233.15 Million | CN¥5.21 Billion | ▼ -0.2 pp |
| 2009 | 94.3% | CN¥3.53 Billion | CN¥201.65 Million | CN¥4.72 Billion | ▼ -1.0 pp |
| 2008 | 95.3% | CN¥3.15 Billion | CN¥147.78 Million | CN¥4.27 Billion | ▲ +2.2 pp |
| 2007 | 93.1% | CN¥2.36 Billion | CN¥163.62 Million | CN¥3.67 Billion | ▼ -4.3 pp |
| 2006 | 97.4% | CN¥2.00 Billion | CN¥52.22 Million | CN¥3.26 Billion | ▲ +0.1 pp |
| 2005 | 97.3% | CN¥1.94 Billion | CN¥53.31 Million | CN¥3.81 Billion | ▲ +1.6 pp |
| 2004 | 95.7% | CN¥1.73 Billion | CN¥74.89 Million | CN¥4.03 Billion | ▲ +0.2 pp |
| 2003 | 95.4% | CN¥1.72 Billion | CN¥78.53 Million | CN¥4.26 Billion | ▲ +0.2 pp |
| 2002 | 95.3% | CN¥1.60 Billion | CN¥75.87 Million | CN¥3.62 Billion | ▼ -1.7 pp |
| 2001 | 97.0% | CN¥1.49 Billion | CN¥45.23 Million | CN¥2.75 Billion | ▲ +4.0 pp |
| 2000 | 92.9% | CN¥855.27 Million | CN¥60.30 Million | CN¥1.48 Billion | ▲ +1.6 pp |
| 1999 | 91.3% | CN¥711.23 Million | CN¥61.63 Million | CN¥1.18 Billion | ▲ +3.8 pp |
| 1998 | 87.5% | CN¥541.45 Million | CN¥67.48 Million | CN¥741.02 Million | ▼ -12.5 pp |
| 1997 | 100.0% | CN¥472.91 Million | CN¥0.00 | CN¥574.69 Million | ▲ +0.0 pp |
| 1996 | 100.0% | CN¥105.81 Million | CN¥0.00 | CN¥154.30 Million | ▲ +0.0 pp |
| 1995 | 100.0% | CN¥103.12 Million | CN¥0.00 | CN¥132.29 Million | ▲ +0.0 pp |
| 1994 | 100.0% | CN¥94.91 Million | CN¥0.00 | CN¥131.33 Million | — |